Karina Pesce, Abstract Co-Author: Nothing to Disclose

Flavia Beatriz Sarquis MD, Presenter: Nothing to Disclose

Bernardo Oscar Blejman MD, Abstract Co-Author: Nothing to Disclose

Carlos Mariano Lamattina MD, Abstract Co-Author: Nothing to Disclose

Fabiana Gisela Vega MD, Abstract Co-Author: Nothing to Disclose

To analyze the history evolution of the management of the axilla in early breast cancer To discuss the diagnostic value of pre-surgery axillary ultrasound for nodal staging in patients with early breast cancer To define a sonographically normal anatomy and normal appearing axillary lymph node To describe the spectrum of sonographic findings in axillary pathologic lymphadenopathy To discuss false positive and negative value of axillary us.  

1-Introduction 2-History evolution of the management of the axilla in early breast cancer 3-Ultrasound anatomy of the axilla and normal sonographic appearance of a lymph node 4-Differentiation of malignant vs. benign axillar nodes with imaging and pathological correlation will be illustrated 5-Limits, false positive and negatives of the axillary ultrasound 6-Role of the detection of axillary nodes in the staging of early breast cancer will be discussed 7- Conclusion  

http://abstract.rsna.org/uploads/2014/14014421/14014421_o2ll.pdf

Pesce, K, Sarquis, F, Blejman, B, Lamattina, C, Vega, F, A New Era in Axillary Management in Early Breast Cancer: The Gold Star is Ultrasound.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14014421.html